Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
西南部落国家的美洲印第安人参与癌症基因组测序
基本信息
- 批准号:10759095
- 负责人:
- 金额:$ 14.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-02 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
While American Indian (AI) Tribes and communities are highly diverse in ethnicity, language, and culture, there
is one unfortunate characteristic that they share: profound cancer health disparities. Compounded by
disproportionately low rates of cancer screening and more limited access to healthcare, AI are more often
diagnosed at later stages of disease and have the poorest outcomes in all types of cancer when compared to
any other racial and ethnic group in the United States. The cause of these significant cancer health disparities is
undoubtedly multifactorial. However, an unexplored factor is the molecular characterization of tumors arising in
AI. American Indians and Alaska Natives (AN) have been strikingly understudied in The Cancer Genome Atlas
Project (TCGA) and account for only < 0.5% of the cancer patients studied. Of the nearly 11,000 patients
sequenced in TCGA to date, only 27 (0.25%) were identified as AI/AN. It is our hypothesis that through
appropriate participant and community engagement and comprehensive genomic sequencing, we will discover
novel somatic and germline mutations, differences in the spectrum and/or frequency of cancer-promoting
mutations, and genome-wide mutational signatures reflective of behaviors and exposures, that can ultimately be
translated to improved cancer screening, precision prevention, and therapeutic intervention in American Indian
participants and communities. In this application, we will focus on the molecular characterization of cancers
which show significant disparities in AI of the Southwest, including gastrointestinal and hepatobiliary cancers
(stomach, colorectal, pancreatic, liver, gallbladder and biliary tree); genitourinary cancers (kidney, prostate
cancer); and other hormone-dependent cancers (breast, ovarian cancers). Our Specific Aims are to develop
culturally-appropriate, respectful, and trusted means to: 1) Engage American Indian participants (cancer patients
and survivors) and their Tribal communities in participatory research studies of the molecular characterization of
cancer, particularly focusing on cancers that display striking disparities in incidence and outcome in Southwest
Tribal Nations; 2) Discover novel somatic and germline mutations and/or differences in the spectrum and
frequency of cancer-promoting mutations, and genome-wide mutational signatures reflective of specific
behaviors and exposures, in American Indian participants, relative to other racial and ethnic populations in the
U.S. and the world; 3) Disseminate knowledge gained through these studies to Tribal participants and Tribal
Councils, leaders, stakeholders, and communities using unique means of participant engagement and novel
means of communication, such as visual arts and media, that are sensitive to cultural and religious beliefs and
practices and that acknowledge the indigenous languages and dialects, many of which lack many scientific and
medical terms for words and concepts such as cancer, gene, genomics, mutation, and DNA, and 4) (Share
knowledge with the broader scientific community through the NCI Genome Data Commons and publication of
scientific results in accordance with NIH Data Sharing Policies and Tribal Agreements.
尽管美洲印第安人(AI)部落和社区在种族,语言和文化方面高度多样化,但
他们共享的一个不幸的特征是:严重的癌症健康差异。复杂
AI的癌症筛查率不成比例低,获得医疗保健的机会更高,因此
在疾病的后期诊断,与
美国的任何其他种族和族裔。这些重大癌症健康差异的原因是
无疑是多因素。但是,未开发的因素是肿瘤的分子表征
人工智能。美洲印第安人和阿拉斯加原住民(AN)在癌症基因组地图集中已经大量研究了
项目(TCGA)仅占研究的癌症患者的<0.5%。在近11,000名患者中
迄今为止在TCGA中测序,仅将27(0.25%)识别为AI/AN。我们的假设是通过
适当的参与者和社区参与以及全面的基因组测序,我们将发现
新型的体细胞和种系突变,促进癌症的频谱和/或频率的差异
突变以及全基因组的突变特征反映了行为和暴露的反映,最终可能是
转化为改善美洲印第安人的癌症筛查,预防精度和治疗干预
参与者和社区。在此应用中,我们将重点关注癌症的分子表征
在西南的AI中显示出很大的差异,包括胃肠道和肝癌
(胃,结直肠,胰腺,肝脏,胆囊和胆汁树);泌尿生殖器癌(肾脏,前列腺
癌症);和其他依赖激素的癌症(乳腺癌,卵巢癌)。我们的具体目的是发展
具有文化适当,尊重和值得信赖的手段:1)与美洲印第安人参与(癌症患者)
和幸存者)及其部落社区在参与性研究中有关分子表征的研究研究
癌症,尤其是专注于在西南部表现出明显差异和结果的癌症
部落国家; 2)发现新型的体细胞和种系突变和/或频谱中的差异
促进癌症突变的频率和全基因组突变特征反映了特定
在美洲印第安人参与者中,相对于其他种族和种族人口的行为和暴露
美国和世界; 3)通过这些研究将知识传播给部落参与者和部落
理事会,领导人,利益相关者和社区使用独特的参与者和新颖的方式
对文化和宗教信仰敏感的视觉艺术和媒体等交流手段
实践和承认土著语言和方言,其中许多语言缺乏许多科学的语言和方言
癌症,基因,基因组学,突变和DNA等单词和概念的医学术语以及4)(共享
通过NCI基因组数据共享与更广泛的科学界的知识,并发布
科学结果符合NIH数据共享政策和部落协议。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Exploring human biology with N-of-1 clinical trials.
通过 N-of-1 临床试验探索人类生物学。
- DOI:10.1017/pcm.2022.15
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Schork,NJ;Beaulieu-Jones,B;Liang,WS;Smalley,S;Goetz,LH
- 通讯作者:Goetz,LH
Does Modulation of an Epigenetic Clock Define a Geroprotector?
- DOI:10.20900/agmr20220002
- 发表时间:2022-03
- 期刊:
- 影响因子:0
- 作者:N. Schork;B. Beaulieu-Jones;Winnie S. Liang;S. Smalley;L. Goetz
- 通讯作者:N. Schork;B. Beaulieu-Jones;Winnie S. Liang;S. Smalley;L. Goetz
Interrogating the Human Diplome: Computational Methods, Emerging Applications, and Challenges.
- DOI:10.1007/978-1-0716-2819-5_1
- 发表时间:2023-01-01
- 期刊:
- 影响因子:0
- 作者:Chan, Agnes P;Choi, Yongwook;Schork, Nicholas J
- 通讯作者:Schork, Nicholas J
A time-series analysis of blood-based biomarkers within a 25-year longitudinal dolphin cohort.
- DOI:10.1371/journal.pcbi.1010890
- 发表时间:2023-03
- 期刊:
- 影响因子:4.3
- 作者:
- 通讯作者:
共 4 条
- 1
JEFFREY M. TRENT的其他基金
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
西南部落国家的美洲印第安人参与癌症基因组测序
- 批准号:1025192910251929
- 财政年份:2020
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing - Diversity Supplement
西南部落国家的美洲印第安人参与癌症基因组测序 - Diversity Supplement
- 批准号:1058429910584299
- 财政年份:2020
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
西南部落国家的美洲印第安人参与癌症基因组测序
- 批准号:1070078910700789
- 财政年份:2020
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
人类转移性黑色素瘤肿瘤背景脆弱性的基因组分析
- 批准号:74549667454966
- 财政年份:2007
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
人类转移性黑色素瘤肿瘤背景脆弱性的基因组分析
- 批准号:73000477300047
- 财政年份:2007
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
人类转移性黑色素瘤肿瘤背景脆弱性的基因组分析
- 批准号:76280307628030
- 财政年份:2007
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
相似国自然基金
卫星互联网端到端安全传输模型与安全路由协议研究
- 批准号:62302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
中继通信协议下2-D网络化系统的递推状态估计研究
- 批准号:62373103
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新型实用化量子密码协议的高安全等级理论分析
- 批准号:12374473
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
云边端架构下联邦学习下行通信压缩算法与协议研究
- 批准号:62372487
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
面向实际应用的测量设备无关类量子密钥分发协议研究
- 批准号:62371244
- 批准年份:2023
- 资助金额:53.00 万元
- 项目类别:面上项目
相似海外基金
PREP-MT: Providing Research Education for Postbaccalaureate Trainees in Montana
PREP-MT:为蒙大拿州的学士后学员提供研究教育
- 批准号:1077228210772282
- 财政年份:2023
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Building Tribal Capacity through Informing the Development of Tribal Research Codes to Govern Genomic Research: A Collaboration between Cherokee Nation and the University of Oklahoma
通过制定部落研究代码来管理基因组研究来建设部落能力:切罗基民族与俄克拉荷马大学之间的合作
- 批准号:1070707310707073
- 财政年份:2022
- 资助金额:$ 14.5万$ 14.5万
- 项目类别:
Building Tribal Capacity through Informing the Development of Tribal Research Codes to Govern Genomic Research: A Collaboration between Cherokee Nation and the University of Oklahoma
通过制定部落研究代码来管理基因组研究来建设部落能力:切罗基民族与俄克拉荷马大学之间的合作
- 批准号:1043844510438445
- 财政年份:2022
- 资助金额:$ 14.5万$ 14.5万
- 项目类别: